Literature DB >> 27300434

YAP/TAZ at the Roots of Cancer.

Francesca Zanconato1, Michelangelo Cordenonsi2, Stefano Piccolo3.   

Abstract

YAP and TAZ are highly related transcriptional regulators pervasively activated in human malignancies. Recent work indicates that, remarkably, YAP/TAZ are essential for cancer initiation or growth of most solid tumors. Their activation induces cancer stem cell attributes, proliferation, chemoresistance, and metastasis. YAP/TAZ are sensors of the structural and mechanical features of the cell microenvironment. A number of cancer-associated extrinsic and intrinsic cues conspire to overrule the YAP-inhibiting microenvironment of normal tissues, including changes in mechanotransduction, inflammation, oncogenic signaling, and regulation of the Hippo pathway. Addiction to YAP/TAZ thus potentially represents a central cancer vulnerability that may be exploited therapeutically.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27300434      PMCID: PMC6186419          DOI: 10.1016/j.ccell.2016.05.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  223 in total

1.  An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer.

Authors:  Satoshi Noguchi; Akira Saito; Masafumi Horie; Yu Mikami; Hiroshi I Suzuki; Yasuyuki Morishita; Mitsuhiro Ohshima; Yoshimitsu Abiko; Johanna Sofia Margareta Mattsson; Helena König; Miriam Lohr; Karolina Edlund; Johan Botling; Patrick Micke; Takahide Nagase
Journal:  Clin Cancer Res       Date:  2014-06-20       Impact factor: 12.531

2.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Authors:  Giorgio G Galli; Matteo Carrara; Wei-Chien Yuan; Christian Valdes-Quezada; Basanta Gurung; Brian Pepe-Mooney; Tinghu Zhang; Geert Geeven; Nathanael S Gray; Wouter de Laat; Raffaele A Calogero; Fernando D Camargo
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

3.  SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.

Authors:  Helen B Pearson; Pedro A Perez-Mancera; Lukas E Dow; Andrew Ryan; Pierre Tennstedt; Debora Bogani; Imogen Elsum; Andy Greenfield; David A Tuveson; Ronald Simon; Patrick O Humbert
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

4.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Transduction of mechanical and cytoskeletal cues by YAP and TAZ.

Authors:  Georg Halder; Sirio Dupont; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

6.  Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.

Authors:  Alizée Boin; Anne Couvelard; Christophe Couderc; Isabel Brito; Dan Filipescu; Michel Kalamarides; Pierre Bedossa; Leanne De Koning; Carine Danelsky; Thierry Dubois; Philippe Hupé; Daniel Louvard; Dominique Lallemand
Journal:  Neuro Oncol       Date:  2014-02-20       Impact factor: 12.300

7.  Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.

Authors:  Alfonso Lavado; Yu He; Joshua Paré; Geoffrey Neale; Eric N Olson; Marco Giovannini; Xinwei Cao
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

8.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

9.  TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Authors:  M Bartucci; R Dattilo; C Moriconi; A Pagliuca; M Mottolese; G Federici; A Di Benedetto; M Todaro; G Stassi; F Sperati; M I Amabile; E Pilozzi; M Patrizii; M Biffoni; M Maugeri-Saccà; S Piccolo; R De Maria
Journal:  Oncogene       Date:  2014-02-17       Impact factor: 9.867

10.  Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.

Authors:  Masahiro Tsujiura; Virginia Mazack; Marius Sudol; Hanna G Kaspar; John Nash; David J Carey; Radhika Gogoi
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more
  626 in total

1.  YAP Enhances Tumor Cell Dissemination by Promoting Intravascular Motility and Reentry into Systemic Circulation.

Authors:  David C Benjamin; Joon Ho Kang; Bashar Hamza; Emily M King; John M Lamar; Scott R Manalis; Richard O Hynes
Journal:  Cancer Res       Date:  2020-06-26       Impact factor: 12.701

Review 2.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

3.  LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P.

Authors:  Boon-Shing Tan; Min-Chi Yang; Shaifali Singh; Yu-Chi Chou; Hsin-Yi Chen; Ming-Yang Wang; Yi-Ching Wang; Ruey-Hwa Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

Review 4.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

5.  Targeting YAP Degradation by a Novel 1,2,4-Oxadiazole Derivative via Restoration of the Function of the Hippo Pathway.

Authors:  Eman M E Dokla; Chun-Sheng Fang; Po-Chen Chu; Chih-Shiang Chang; Khaled A M Abouzid; Ching S Chen
Journal:  ACS Med Chem Lett       Date:  2020-03-05       Impact factor: 4.345

6.  Colon cancer stem cells: Potential target for the treatment of colorectal cancer.

Authors:  Riya Gupta; Lokesh Kumar Bhatt; Thomas P Johnston; Kedar S Prabhavalkar
Journal:  Cancer Biol Ther       Date:  2019-05-03       Impact factor: 4.742

7.  Astrocytic YAP Promotes the Formation of Glia Scars and Neural Regeneration after Spinal Cord Injury.

Authors:  Changnan Xie; Xiya Shen; Xingxing Xu; Huitao Liu; Fayi Li; Sheng Lu; Ziran Gao; Jingjing Zhang; Qian Wu; Danlu Yang; Xiaomei Bao; Fan Zhang; Shiyang Wu; Zhaoting Lv; Minyu Zhu; Dingjun Xu; Peng Wang; Liying Cao; Wei Wang; Zengqiang Yuan; Ying Wang; Zhaoyun Li; Honglin Teng; Zhihui Huang
Journal:  J Neurosci       Date:  2020-02-17       Impact factor: 6.167

8.  EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.

Authors:  Jianchun Chen; Huaizhou You; Yan Li; You Xu; Qian He; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2018-08-02       Impact factor: 10.121

Review 9.  Physical traits of cancer.

Authors:  Hadi T Nia; Lance L Munn; Rakesh K Jain
Journal:  Science       Date:  2020-10-30       Impact factor: 47.728

10.  Metabolic Reprogramming Promotes Neural Crest Migration via Yap/Tead Signaling.

Authors:  Debadrita Bhattacharya; Ana Paula Azambuja; Marcos Simoes-Costa
Journal:  Dev Cell       Date:  2020-04-02       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.